My son is currently attending USAFA as a C2C in his second semester. His GPA and class rank are good. He has been in the deans list the past two semesters. Now the question, in the summer after completing his freshman year a mile was discovered. It was termed malignant melanoma. It was successfully removed and all SNB listed as clear. No additional medical attention needed other than a visit to the dermatologist every three months. He recently received a letter from his AOC that a medical waiver was denied. We did not know one was being sought as he had a clean bill from the surgeon. Now we are in the process of requesting an exception. How likely will this be granted? I have obtained a letter from the surgeon and also contacted the dermatologist which would speak in his behalf. The surgeon has written in his letter thatnjn his treatment of 1000’s of patients over 22 years with a similar case as my son he has only seen one reoccurrence.
Any input or direction is appreciated
Follow the process, and I agree with discussing with the for-profit DODMERB consultant firm. The firm owner was formerly at DODMERB, and comments here on SAF tend toward the positive. Exhaust all avenues.
The pre-comm accession bar is set higher than for conditions which develop after becoming an officer. While those accession standards often vary by Service, pre-existing cancer, though currently corrected, is a tough hurdle. There are people on AD who are melanoma survivors, who, with appropriate follow-up care, can continue serving - but it was diagnosed and treated after accession.
Though there are many reasons for the higher standard, including reducing risk of impact in operational readiness, the Service takes on on obligation with regard to health care, while on AD, and afterwards, that obligation shifts to DVA, for both Service-connected and combat-connected conditions, for a lifetime.
Here’s some reading at the link below. I don’t know if it’s the most current standard for DOD, but the current document for DOD and the derivative AF one will be the reference for decisions.
See p. 77